MLH1 and colorectal carcinoma: Indeed, upon excluding dMMR/MSI CRC patients with MLH1 promoter hypermethylation and germline mutations, biallelic somatic inactivation is responsible for approximately 50% of the remaining dMMR/MSI CRCs [51].